Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity

…, C Rousselle, N Dereuddre-Bosquet…

Index: Serradji, Nawal; Martin, Marc; Bensaid, Okkacha; Cisternino, Salvatore; Rousselle, Christophe; Dereuddre-Bosquet, Nathalie; Huet, Jack; Redeuilh, Catherine; Lamouri, Aazdine; Dong, Chang-Zhi; Clayette, Pascal; Scherrmann, Jean-Michel; Dormont, Dominique; Heymans, Francoise Journal of Medicinal Chemistry, 2004 , vol. 47, # 25 p. 6410 - 6419

Full Text: HTML

Citation Number: 19

Abstract

The HIV-1 central nervous system infection leads to the onset of neurological impairments called AIDS dementia complex (ADC). PAF plays an important role in this pathology, as it is an HIV-1-induced neurotoxin produced by infected or activated macrophages and microglia, in the brain. We previously reported that PAF-antagonists bearing a trisubstituted piperazine presented in vitro anti-HIV-1 activity in human macrophages. To improve the ...